Author(s)

Hui Huang, Li Sun, Ling Wang, Lei Fang, Li Zhao, Yan Li

Department of Neurology, The Second Affiliated Hospital, Qingdao University Medical College, Qingdao, China;.
Institute of Inte- grative Medicine, The Second Affiliated Hospital, Qingdao University Medical College, Qingdao, China..

The paper aims to optimize the therapeutic dose and time window of picroside II by orthogonal test in cerebral ischemic injury in rats. The forebrain ischemia models were established by bilateral common carotid artery occlusion (BCCAO) methods. The successful models were randomly divided into sixteen groups according to orthogonal experimental design and treated by injecting picroside II intraperitonenally at different ischemic time with different dose. The concentrations of neuron-specific enolase (NSE), neuroglial marker protein S100B and myelin basic protein (MBP) in serum were determined by enzyme linked immunosorbent assay to evaluate the therapeutic effect of picroside II in cerebral ischemic injury. The results indicated that best therapeutic time window and dose of picroside II in cerebral ischemic injury were ischemia 1.5 h with 20 mg/kg body weight according to the concentrations of NSE, S100B and MBP in serum. It is concluded that according to the principle of lowest therapeutic dose with longest time window, the optimized therapeutic dose and time window are injecting picroside II intraperitonenally with 20 mg/kg body weight at ischemia 1.5 h in cerebral ischemic injury in rats.

Picroside II; Cerebral Ischemia; Therapeutic Dose; Time Window; Rats

H. Huang, L. Sun, L. Wang, L. Fang, L. Zhao and Y. Li, "To Optimize the Therapeutic Dose and Time Window of Picroside II in Cerebral Ischemic Injury in Rats by Orthogonal Test," Neuroscience and Medicine, Vol. 4 No. 3, 2013, pp. 166-171. doi: 10.4236/nm.2013.43027.